Global Cancer Tumor Profiling Market Analysis & Industry Forecast 2017-2023, With an Expected CAGR of 18.4% - ResearchAndMarkets.com

DUBLIN--()--The "Cancer Tumor Profiling Market by Technology [Next-generation Sequencing - Global Opportunity Analysis and Industry Forecast, 2017-2023" report has been added to ResearchAndMarkets.com's offering.

The global market is driven by increase in adoption of the cancer profiling methods by oncologists, rise in use of cancer biomarkers, surge in prevalence of cancer, and growth in demand for next-generation sequencing technique to meet the demand for cancer profiling. The global cancer/tumor profiling market was valued at $25,318 million in 2016, and is expected to reach $82,447 million by 2023, registering a CAGR of 18.4% from 2017 to 2023.

Cancer/tumor profiling uses several molecular biology techniques, such as microarray, polymerase chain reaction (PCR), and in situ hybridization (ISH), to provide specific information about genetic and molecular makeup of tumor. It can detect the presence or absence of distinct disease-associated targets that guide medical practitioners in deciding the appropriate course of treatment for patients. In addition, it enables estimating individual patient risk to cancer by performing high throughput genotyping analysis of tumor DNA and predicting the reaction outcome of the therapy.

The global cancer/tumor profiling market is segmented on the basis of technology, technique, application, and region. Based on technology, it is classified into next-generation sequencing (NGS), polymerase chain reaction (PCR), immunohistochemistry (IHC), in situ hybridization (ISH), microarray, and others. The in-situ hybridization segment is further categorized into fluorescence in situ hybridization (FISH) and chromogenic in situ hybridization (CISH). Based on technique, it is divided into genomics, proteomics, epigenetics, and metabolomics.

Companies Mentioned:

  • Qiagen N.V.
  • Roche Molecular Systems Inc.
  • Abbott Molecular
  • Illumina Inc.
  • NeoGenomics Laboratories
  • HTG Molecular Diagnostic
  • Genomic Health Inc.
  • Hologic Gen-Probe
  • BD Biosciences
  • Siemens Healthineers

Key Topics Covered:

1. Introduction

2. Executive Summary

3. Market Overview

4. Cancer/Tumor Profiling Market, By Technology

5. Cancer/Tumor Profiling Market, By Technique

6. Cancer/Tumor Profiling Market, By Application

7. Cancer/Tumor Profiling Market, By Geography

8. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/mnsqns/global_cancer?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Diagnostics, Molecular Diagnostics

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Diagnostics, Molecular Diagnostics